A recently established technique termed pharming uses genetically modified plants and animals for the production of biopharmaceuticals. The present interdisciplinary study comprises an extended overview of the state of the art of pharming, as well as in depth analyses of the environmental risks and other ethical and legal issues of pharming. Public attitudes to pharming are investigated on the basis of an original survey in 15 countries worldwide. The study concludes with specific recommendations addressed towards science, industry and politics.

Der Mangel an Spenderorganen in der Transplantationsmedizin ist ein Thema von hoher gesellschaftlicher Relevanz. Da jedes Jahr in Deutschland nahezu 1.000 Patienten auf der Warteliste sterben und etwa 12.000 Patienten auf der Warteliste teilweise grosses Leid ertragen, darf die Gesellschaft den Organmangel nicht ignorieren, sondern muss immer wieder von neuem nach Losungen suchen und ohne Tabus uber unterschiedliche Handlungsoptionen diskutieren. Die vorliegende Studie ist das Ergebnis einer interdisziplinaren Forschungsarbeit. Sie geht den Ursachen des Organmangels auf den Grund und zeigt...

A recently established technique termed pharming uses genetically modified plants and animals for the production of biopharmaceuticals. The present interdisciplinary study comprises an extended overview of the state of the art of pharming, as well as in depth analyses of the environmental risks and other ethical and legal issues of pharming. Public attitudes to pharming are investigated on the basis of an original survey in 15 countries worldwide. The study concludes with specific recommendations addressed towards science, industry and politics.